Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
PK Lead-in phase is: To evaluate the steady state pharmacokinetics (PK) and confirm the dose of sofosbuvir/velpatasvir (SOF/VEL) in pediatric subjects with chronic hepatitis C virus (HCV) infection Treatment Phase is: To evaluate the safety and tolerability of SOF/VEL for 12 weeks in paediatric subjects with chronic HCV
Critère d'inclusion
- Chronic hepatitis C virus infection